Get Started

ARWR

NASD Arrowhead Pharmaceuticals, Inc.
Oct 28, 2026 · 10:29 AM ET DELAYED Market Open

$59.14 ↑ +0.11 (+0.19%) Trading Up from the previous close of $59.03, $0.50 below the day’s high of $59.64

YTD change
-10.92%
vs 20-day SMA
-1.79%
vs 200-day SMA
-17.65%

Price ranges

Previous day
$58.01 $60.56
open $59.02 close $59.03
+$0.01 (+0.02%)
Today
$58.20 $59.64
open $58.64 now $59.14
+$0.50 (+0.85%)
Past week
$56.56 $60.56
from $58.92 now $59.14
+$0.22 (+0.37%)
Past month
$55.83 $66.80
from $66.25 now $59.14
-$7.11 (-10.73%)
This year
$54.02 $95.49
from $66.39 now $59.14
-$7.25 (-10.92%)

Price & Performance

-11.10 (-15.83%) / 6M

$53.20$66.23$79.26$92.29Apr 28Jul 29Oct 27

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 38.1% away from all-time highs of $95.49
  • ARWR is down 11% since the beginning of the year
  • ARWR is up 50% over the past 12 months
  • ARWR is down 11% over the past 1 month
  • 8% of all ARWR investors are betting against ARWR

ARWR reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +49.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.36
Earnings momentum +10.4% Quarterly EPS growth
Quarterly change +10.4%

Valuation

P/E ratio N/A
Enterprise value $8.2B
Beta 2.23

Balance sheet & scale

IncomeN/A
Revenue$669.5M
Cash$1.6B
Debt$1.4M
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $8.4B

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $447.95 +0.75%
MRNA Moderna, Inc. $207.97 +4.59%
RVMD Revolution Medicines, Inc. $186.22 +1.26%
ROIV Roivant Sciences Ltd. $36.54 +1.36%
BNTX BioNTech SE Sponsored ADR $87.06 +0.23%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.